Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 7, 2019
Deep learning to automate Brasfield chest radiographic scoring for cystic fibrosis
Evan J Zucker, Zachary A Barnes, Matthew P Lungren, et al.
Journal of Epidemiology and Global Health
|
November 17, 2025
Leukemia Incidence and Demographic Trends in Saudi Arabia, 1997-2022: A Nationwide Registry Analysis
Hibah A Almasmoum, Afnan S Salaka, Imtinan Y Alamri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study
P W Kantoff, S Halabi, M Conaway, et al.
Patient Education and Counseling
|
June 1, 2001
The short-term impact of tailored mammography decision-making interventions
B K Rimer, S Halabi, C Sugg Skinner, et al.
Ultrasound Quarterly
|
March 15, 2019
Sonographic Diagnosis of Velamentous and Marginal Placental Cord Insertion
Brendan P Kelley, Chad L Klochko, Sarah Atkinson, et al.
Archives of Internal Medicine
|
July 24, 2001
Women's interest in chemoprevention for breast cancer
L A Bastian, I M Lipkus, M N Kuchibhatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B
D M Savarese, S Halabi, V Hars, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473
C P Burns, S Halabi, G H Clamon, et al.
Cancer Research
|
April 6, 2001
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study
R A Bok, S Halabi, D T Fei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
J E Rosenberg, S Halabi, B L Sanford, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 7, 2019
Deep learning to automate Brasfield chest radiographic scoring for cystic fibrosis
Evan J Zucker, Zachary A Barnes, Matthew P Lungren, et al.
Journal of Epidemiology and Global Health
|
November 17, 2025
Leukemia Incidence and Demographic Trends in Saudi Arabia, 1997-2022: A Nationwide Registry Analysis
Hibah A Almasmoum, Afnan S Salaka, Imtinan Y Alamri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study
P W Kantoff, S Halabi, M Conaway, et al.
Patient Education and Counseling
|
June 1, 2001
The short-term impact of tailored mammography decision-making interventions
B K Rimer, S Halabi, C Sugg Skinner, et al.
Ultrasound Quarterly
|
March 15, 2019
Sonographic Diagnosis of Velamentous and Marginal Placental Cord Insertion
Brendan P Kelley, Chad L Klochko, Sarah Atkinson, et al.
Archives of Internal Medicine
|
July 24, 2001
Women's interest in chemoprevention for breast cancer
L A Bastian, I M Lipkus, M N Kuchibhatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B
D M Savarese, S Halabi, V Hars, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473
C P Burns, S Halabi, G H Clamon, et al.
Cancer Research
|
April 6, 2001
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study
R A Bok, S Halabi, D T Fei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
J E Rosenberg, S Halabi, B L Sanford, et al.
Page
of 12